文献速递心力衰竭与心肌病心律失常

心力衰竭的电学管理:从病理生理到治疗

Electrical management of heart failure: from pathophysiology to treatment.
PubMed 文献 · Eur Heart J · 2022-01-01

本综述聚焦射血分数降低的心力衰竭(HFrEF),阐述房颤、失同步、心动过速和室性早搏等电学异常既可继发于心衰,也可致病或加重心衰;临床研究显示导管消融与心脏再同步化治疗(CRT)安全有效,但应用严重不足。

要点

  • 房颤患者中,心房及肺静脉消融在节律控制、房室结消融在心率控制方面均优于药物治疗。
  • 室性早搏消融可改善左心室功能。
  • CRT是已确立的辅助治疗,指南已反映其安全性与有效性,但当前应用严重不足。

核心结论

  • 电学异常既可能是心衰的结果,也可能导致或加重心衰,电学治疗可逆转或减轻心衰。
  • 治疗心衰患者的专家团队应纳入电生理医生,以推动电学治疗在HFrEF管理中的更广泛应用。
  • 治疗精细调整还应纳入患者个体情况,如体型和性别。

研究设计与样本

  • 综述,聚焦射血分数降低的心力衰竭(HFrEF)的电学治疗,汇总动物研究与临床研究证据。
  • 动物研究显示,持续时间较长的左束支传导阻滞、心动过速、房颤和室性早搏可在器官、细胞和分子水平导致功能异常。

主要发现

  • 多数心衰患者存在房颤、失同步、心动过速和室性早搏等电学异常。
  • 临床研究显示,房颤患者中心房及肺静脉消融用于节律控制、房室结消融用于心率控制均优于药物治疗。
  • 室性早搏消融可改善左心室功能。
  • 心脏再同步化治疗(CRT)是已确立的辅助治疗,目前正经历多项有意义的创新。

临床怎么用

  • 当前指南推荐反映了上述消融治疗和CRT的安全性与有效性,但目前这些治疗应用严重不足。
  • 治疗心衰患者的专家团队应纳入电生理医生,以促进电学治疗在HFrEF管理中的更广泛应用。
  • 治疗精细调整应考虑患者个体情况,如体型和性别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Electrical disturbances, such as atrial fibrillation (AF), dyssynchrony, tachycardia, and premature ventricular contractions (PVCs), are present in most patients with heart failure (HF). While these disturbances may be the consequence of HF, increasing evidence suggests that they may also cause or aggravate HF. Animal studies show that longer-lasting left bundle branch block, tachycardia, AF, and PVCs lead to functional derangements at the organ, cellular, and molecular level. Conversely, electrical treatment may reverse or mitigate HF. Clinical studies have shown the superiority of atrial and pulmonary vein ablation for rhythm control and AV nodal ablation for rate control in AF patients when compared with medical treatment. Ablation of PVCs can also improve left ventricular function. Cardiac resynchronization therapy (CRT) is an established adjunct therapy currently undergoing several interesting innovations. The current guideline recommendations reflect the safety and efficacy of these ablation therapies and CRT, but currently, these therapies are heavily underutilized. This review focuses on the electrical treatment of HF with reduced ejection fraction (HFrEF). We believe that the team of specialists treating an HF patient should incorporate an electrophysiologist in order to achieve a more widespread use of electrical therapies in the management of HFrEF and should also include individual conditions of the patient, such as body size and gender in therapy fine-tuning.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Prinzen, Auricchio, Mullens, et al. Electrical management of heart failure: from pathophysiology to treatment. Eur Heart J. 2022. PMID: 35265992. doi:10.1093/eurheartj/ehac088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。